One of the largest teams of statisticians and SAS programmers in Europe within a company is at your service, supporting the planning of your project, during the conduct or reporting phases with solutions that fit your needs:

The AMS  Biostatistics team has a long track record of successfully completed projects in a wide range of indications, from Phase I to IV, non-interventional projects, patient registries, epidemiological studies and outcomes research in projects for pharmaceuticals and medical devices, and for national and international projects.


Read more how AMS  Biostatistics services fit your needs!


Talk or write to us:



• 2021 – New Literature Search tool launched • 2021 – DIGA dossier submission pioneer • 2021 – NIS-eTMF launched • 2021 – MDR readiness, AMS prepared for Medical Device Trials under new regulation • 2021 – VO (EU) 536/2014, AMS among the first 100 participants in the EMA CTIS Trainer Programme • 2021 – eSignature, AMS introduced DocuSign® • 2017 – Globally unique AMS-ePRO® features • 2016 – CRO of the year award •